Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hibernation Therapeutics
Wicklow, Ireland
- Ownership
- Private
- Development stage
- Other
01
Overview
Hibernation Therapeutics developed adenocaine cardioplegic and microplegia solutions for myocardial protection in cardiac surgery, which have been commercialized via pharmacy outsourcing and admixture partners such as Leiters and CAPS for use in clinical practice.[1][2] Patent filings also describe broader use of their compositions to reduce tissue and organ injury after trauma and ischemia-reperfusion, but no clinical trial or regulatory data beyond use as cardioplegia solutions are publicly detailed.[1][2][8]
- Therapeutic areas
- CardiovascularOther
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
Leiters[1]Central Admixture Pharmacy Services (CAPS), a B. Braun company[2]
Beyond the preview
Go deeper on Hibernation Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hibernation Therapeutics.